PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsPure red-cell aplasia
MeSH D012010 - pure red-cell aplasia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D000740:Anemia
25 Companies
17 Drugs
$
Success rate
D012010: 
Pure red-cell aplasia
17 Companies
1 Drug
$
Success rate
D029503:Diamond-blackfan anemia
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaCyclophosphamide Neosar  1993-04-29   
Dr Reddys LaboratoriesCyclophosphamide Cyclophosphamide 2036-02-15 2020-07-30   
CiplaCyclophosphamide Cyclophosphamide  2019-01-18   
Alembic PharmaceuticalsCyclophosphamide Cyclophosphamide  2022-11-10   
Amneal PharmaceuticalsCyclophosphamide Cyclophosphamide  2018-05-25   
ANI PharmaceuticalsCyclophosphamide Cyclophosphamide  2018-03-19   
Hikma PharmaceuticalsCyclophosphamide Cyclophosphamide  2013-09-16   
Roxane LaboratoriesCyclophosphamide Cyclophosphamide  1999-08-17   
Eugia Pharma SpecialtiesCyclophosphamide Cyclophosphamide 2035-06-26 2021-08-25   
BaxterCyclophosphamide Cyclophosphamide  2008-05-21   
Cyclophosphamide Cytoxan  1982-01-01   
Cyclophosphamide Cytoxan (lyophilized)  1982-01-01   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
14%
1/7
Phase 3
100%
1/1
Approved: 1Overall Success rate: 14%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Cyclophosphamide
Baxter
Cyclophosphamide
Jiangsu Hengrui Medicine
Cyclophosphamide
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use